HIV+Hep Welcomes New HHS Secretary

We stand ready to work with Secretary Kennedy as he and President Trump seek to improve the health of the American people. Ending infectious and chronic diseases, such as HIV and hepatitis, must be a vital component in the administration’s initiatives. To deliver on the promise of eradicating HIV will require a commitment to science, properly funded public health treatment and prevention programs, and policies that support all populations impacted by HIV. It will also require access to affordable and comprehensive health coverage, including private insurance, Medicaid and Medicare.
See the press release

20 HIV & Hepatitis Organizations Urge the U.S. Supreme Court to Protect Preventive Services Coverage

The HIV+Hepatitis Policy Institute led 19 other HIV and hepatitis organizations in filing an amicus brief in Kennedy v Braidwood before the Supreme Court to defend the Affordable Care Act preventive services mandate and ensure that HIV & hepatitis testing and PrEP continue to be covered by insurers without cost-sharing.
See the press release

Insurer Agrees to Add HIV Drugs After Discrimination Complaint Filed

“While this action is certainly welcome, the fact remains that Harvard Pilgrim removed lifesaving HIV drugs from its coverage formulary, disrupted the treatment of people living with HIV, and violated the ACA’s nondiscrimination protections,” said Carl Schmid, executive director of the HIV+Hepatitis Policy Institute. “This demonstrates the need for greater oversight of the health insurance industry and enforcement of the safeguards in place to protect patients against the abuse of insurers.”
See the press release

Biden-Harris Administration Sides with Insurers & Fails to Take Steps to Lower Patient Costs for Prescription Drugs

Every day these rules are delayed is another day that insurers and PBMs are pocketing billions of dollars meant for patients who are struggling to afford their drugs. Coming from an administration that prides itself on supporting patients and lowering their prescription drug costs, this is a huge disappointment. While they have gone on record that they will issue these rules, the clock is ticking and there isn’t much time left.
See the press release

Senate Appropriators Maintain Funding for Domestic HIV and Hepatitis Programs

Instead of providing new investments in ending HIV by increasing funding for testing, prevention programs, such as PrEP, and life-saving care and treatment, House Republicans are again choosing to go through a worthless exercise of cutting programs that the American people depend on and will never pass.
See the press release

House Proposes to Gut Ending HIV Programs—Again

Instead of providing new investments in ending HIV by increasing funding for testing, prevention programs, such as PrEP, and life-saving care and treatment, House Republicans are again choosing to go through a worthless exercise of cutting programs that the American people depend on and will never pass. These were purposeful decisions that are well below the agreed-upon budget caps. While we will vigorously fight these cuts, we look forward to working with the entire Congress in a bipartisan fashion on spending bills that can actually become law.
See the press release

Who We Are

Monitors policies that impact the prevention and treatment of HIV, viral hepatitis, and other health conditions in the United States.

Communicates with members of the HIV, hepatitis, and other patient group communities on key policy issues that impact their access to healthcare.

Educates policymakers and members of the media about efforts to end both HIV and hepatitis in the United States and to improve access to quality and affordable healthcare for people with or at risk of serious or chronic health conditions.

Key Issues

Causes We Care About, and So Should You!

HIV

Promote necessary funding, programs, and policies to end the HIV epidemic in the United States

HEPATITIS

Promote necessary funding, programs, and policies to end viral hepatitis in the United States

HEALTHCARE ACCESS

Promote necessary funding, programs, and policies to end viral hepatitis in the United States

Learn More

Facebook posts by @HIV+Hep

HIV and Hepatitis Policy Institute

1 week ago

HIV and Hepatitis Policy Institute
The Case for HIV Prevention and Screening--Pay Today or Pay Tomorrow: www.contagionlive.com/view/the-case-for-hiv-preventative-and-testing-pay-today-or-pay-tomorrow ... See MoreSee Less

Photo

View on Facebook
· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Tweets by @HIV+Hep

Pin It on Pinterest